Get the Stockscreener App
9.05
0.56%
0.05
Eyepoint Pharmaceuticals Inc Stock (EYPT) Forecast
The Eyepoint Pharmaceuticals Inc (EYPT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $34.30, representing a +278.98% increase from the current price of $9.05. The highest analyst price target is $35.27, and the lowest is $33.33.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EYPT Price Target
Average 46.36
(+412.23% Upside)
Is Eyepoint Pharmaceuticals Inc (EYPT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.70 | Neutral |
| STOCH(9,6) | 23.15 | Neutral |
| STOCHRSI(14) | 28.56 | Neutral |
| MACD(12,26) | -0.4082 | Sell |
| ADX(14) | 25.13 | Sell |
| William %R | -78.91 | Neutral |
| CCI(14) | -48.64 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.0985
Sell
|
9.3377
Sell
|
| MA20 |
10.36
Sell
|
9.7807
Sell
|
| MA50 |
9.7835
Sell
|
9.8465
Sell
|
| MA100 |
9.3351
Sell
|
10.23
Sell
|
| MA200 |
13.15
Sell
|
11.16
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, EYPT could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 12 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on EYPT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.7 indicates that EYPT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 23.15 indicates that EYPT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.56 indicates that EYPT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.13 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -48.64 indicates that EYPT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term EYPT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eyepoint Pharmaceuticals Inc financial reports and earnings history, Eyepoint Pharmaceuticals Inc (EYPT) stock could reach $39.59 by 2030, $423.21 by 2040 and $530.83 by 2050. See the projected annual prices until 2050 of the Eyepoint Pharmaceuticals Inc stock below:
- Eyepoint Pharmaceuticals Inc (EYPT) is expected to reach an average price of $317.99 in 2035, with a high prediction of $319.07 and a low estimate of $313.32. This indicates an $3,414% rise from the last recorded price of $9.05.
- Eyepoint Pharmaceuticals Inc (EYPT) stock is projected to chart a bullish course in 2040, with an average price target of $420.52, representing an $4,547% surge from its current level. The forecast ranges from a conservative $412.39 to a sky-high $423.21.
- Our analysts predict Eyepoint Pharmaceuticals Inc (EYPT) to jump 5,306% by 2045, soaring from $484.24 to an average price of $489.20, potentially reaching $491.09. While $484.24 is the low estimate, the potential upside is significant.
- Eyepoint Pharmaceuticals Inc (EYPT) stock is expected to climb by 2050, reaching an average of $529.98, a $5,756% jump from its current level. However, a wide range of estimates exists, with high and low targets of $530.83 and $518.52, respectively, highlighting the market's uncertainty.
Eyepoint Pharmaceuticals Inc Stock (EYPT) Year by Year Forecast
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2024
Our forecast for EYPT stock price in 2024 now indicates an average price target of $25.39 with a high forecast of $35.27 and a low forecast of $15.51. The average prediction reflects an increase of +180.53% from the last recorded price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $35.15 | $33.33 | $35.27 | +288.34% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2025
Eyepoint Pharmaceuticals Inc Stock (EYPT) is expected to reach an average price of $48.77 in 2025, with a high prediction of $61.91 and a low estimate of $35.63. This indicates an +438.91% rise from the last recorded price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $37.74 | $35.63 | $37.85 | +317.01% |
| February, 2025 | $40.23 | $38.19 | $40.46 | +344.57% |
| March, 2025 | $41.72 | $40.68 | $41.92 | +360.98% |
| April, 2025 | $44.06 | $42.21 | $44.11 | +386.81% |
| May, 2025 | $46.10 | $44.31 | $46.16 | +409.42% |
| June, 2025 | $48.08 | $46.57 | $48.23 | +431.29% |
| July, 2025 | $50.79 | $48.58 | $51.06 | +461.17% |
| August, 2025 | $52.76 | $51.14 | $52.77 | +482.93% |
| September, 2025 | $54.80 | $53.22 | $54.85 | +505.53% |
| October, 2025 | $57.22 | $55.21 | $57.28 | +532.25% |
| November, 2025 | $59.35 | $57.72 | $59.38 | +555.76% |
| December, 2025 | $61.83 | $59.85 | $61.91 | +583.17% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2026
The predicted value for Eyepoint Pharmaceuticals Inc (EYPT) in 2026 is set at an average of $81.55. Estimates vary from a peak of $100.75 to a trough of $62.34, indicating an +801.09% surge from the present price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $64.09 | $62.34 | $64.11 | +608.19% |
| February, 2026 | $70.33 | $64.58 | $70.55 | +677.14% |
| March, 2026 | $78.67 | $70.60 | $80.75 | +769.29% |
| April, 2026 | $83.64 | $77.34 | $85.43 | +824.25% |
| May, 2026 | $83.02 | $80.20 | $84.59 | +817.40% |
| June, 2026 | $84.58 | $82.50 | $85.83 | +834.63% |
| July, 2026 | $86.07 | $83.88 | $87.88 | +851.03% |
| August, 2026 | $88.80 | $86.10 | $89.18 | +881.19% |
| September, 2026 | $89.97 | $89.06 | $90.95 | +894.16% |
| October, 2026 | $93.21 | $89.75 | $93.26 | +929.96% |
| November, 2026 | $97.06 | $93.52 | $97.39 | +972.49% |
| December, 2026 | $99.14 | $97.26 | $100.75 | +995.52% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eyepoint Pharmaceuticals Inc (EYPT) is $113.43, with a high forecast of $127.48 and a low forecast of $99.38. This indicates an +1,153% increase from the last price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $102.89 | $99.38 | $103.32 | +1,037% |
| February, 2027 | $110.18 | $102.54 | $114.44 | +1,117% |
| March, 2027 | $109.23 | $108.48 | $111.91 | +1,107% |
| April, 2027 | $107.60 | $107.17 | $111.64 | +1,089% |
| May, 2027 | $109.11 | $106.91 | $109.85 | +1,106% |
| June, 2027 | $113.83 | $109.30 | $114.21 | +1,158% |
| July, 2027 | $116.64 | $114.17 | $117.54 | +1,189% |
| August, 2027 | $119.10 | $117.02 | $119.37 | +1,216% |
| September, 2027 | $118.90 | $116.83 | $119.96 | +1,214% |
| October, 2027 | $119.21 | $118.31 | $120.11 | +1,217% |
| November, 2027 | $121.66 | $118.91 | $121.74 | +1,244% |
| December, 2027 | $127.15 | $121.13 | $127.48 | +1,305% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2028
In 2028, Eyepoint Pharmaceuticals Inc (EYPT) is projected to reach an average price of $139.48, with a high projection of $152.36 and a low estimate of $126.60. This indicates an +1,441% rise from the last price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $127.40 | $126.63 | $128.24 | +1,308% |
| February, 2028 | $128.15 | $126.65 | $128.56 | +1,316% |
| March, 2028 | $128.26 | $126.60 | $128.81 | +1,317% |
| April, 2028 | $128.28 | $128.01 | $129.36 | +1,317% |
| May, 2028 | $130.47 | $128.45 | $130.56 | +1,342% |
| June, 2028 | $133.89 | $130.98 | $134.96 | +1,379% |
| July, 2028 | $135.84 | $134.28 | $136.73 | +1,401% |
| August, 2028 | $136.83 | $135.74 | $137.79 | +1,412% |
| September, 2028 | $139.77 | $137.18 | $139.89 | +1,444% |
| October, 2028 | $145.15 | $140.25 | $147.97 | +1,504% |
| November, 2028 | $147.21 | $144.94 | $147.48 | +1,527% |
| December, 2028 | $152.03 | $147.52 | $152.36 | +1,580% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2029
The 2029 price forecast for Eyepoint Pharmaceuticals Inc Stock (EYPT) is $114.11 on average, with a high prediction of $194.05 and a low estimate of $34.16. This represents an +1,161% increase from the previous price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $158.45 | $151.60 | $158.61 | +1,651% |
| February, 2029 | $159.36 | $158.01 | $163.68 | +1,661% |
| March, 2029 | $160.63 | $158.40 | $162.40 | +1,675% |
| April, 2029 | $160.35 | $158.56 | $161.36 | +1,672% |
| May, 2029 | $161.28 | $159.05 | $162.87 | +1,682% |
| June, 2029 | $163.59 | $161.50 | $163.65 | +1,708% |
| July, 2029 | $182.19 | $174.81 | $183.70 | +1,913% |
| August, 2029 | $188.63 | $178.72 | $189.66 | +1,984% |
| September, 2029 | $190.34 | $188.88 | $194.05 | +2,003% |
| October, 2029 | $188.68 | $187.05 | $193.64 | +1,985% |
| November, 2029 | $186.17 | $185.23 | $191.64 | +1,957% |
| December, 2029 | $34.35 | $34.16 | $188.91 | +279.61% |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Price Forecast for 2030
Eyepoint Pharmaceuticals Inc Stock (EYPT) is expected to reach an average price of $61.78 in 2030, with a high forecast of $88.23 and a low forecast of $35.32. This signifies an +582.62% surge from the last price of $9.05.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $39.41 | $35.32 | $39.59 | +335.45% |
| February, 2030 | $43.60 | $40.45 | $43.74 | +381.74% |
| March, 2030 | $47.58 | $44.55 | $47.68 | +425.70% |
| April, 2030 | $51.97 | $48.52 | $52.04 | +474.25% |
| May, 2030 | $57.52 | $52.95 | $57.52 | +535.62% |
| June, 2030 | $62.13 | $58.37 | $62.61 | +586.51% |
| July, 2030 | $66.59 | $63.09 | $66.72 | +635.76% |
| August, 2030 | $70.83 | $67.60 | $70.89 | +682.65% |
| September, 2030 | $75.11 | $71.86 | $75.16 | +729.93% |
| October, 2030 | $80.60 | $76.12 | $80.79 | +790.63% |
| November, 2030 | $84.04 | $81.26 | $84.22 | +828.57% |
| December, 2030 | $87.98 | $84.89 | $88.23 | +872.11% |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):